SCHEMBL5370461

SCHEMBL5370461

O=C(Nc1cn(-c2c[nH]c(C(F)(F)F)n2)nc1-c1c[nH]c(C(F)(F)F)n1)c1c(F)cccc1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
CDK1 P06493 3/20 0.36
CDK2 P24941 3/20 0.36
ROCK1 Q13464 2/20 0.36
CLK4 Q9HAZ1 2/20 0.36
STK17A Q9UEE5 2/20 0.36
STIM1 Q13586 2/20 0.36
ORAI1 Q96D31 2/20 0.36
ABL1 P00519 2/20 0.36
DYRK3 O43781 1/20 0.36
PRKD3 O94806 1/20 0.36
MAP4K4 O95819 1/20 0.36
EGFR P00533 1/20 0.36
NTRK1 P04629 1/20 0.36
PRKCG P05129 1/20 0.36
LCK P06239 1/20 0.36
FYN P06241 1/20 0.36
FES P07332 1/20 0.36
CSF1R P07333 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3591831 0.79 MEN1 (0.42) MEN1KMT2ACDK1CDK2ROCK1
SCHEMBL5316740 0.70 NPC1 (0.47) MEN1KMT2AABL1MAPTKDM4E
SCHEMBL5578150 0.62 CDK1 (0.45) MEN1KMT2ACDK1CDK2ROCK1
SCHEMBL5578299 0.61 CDK1 (0.43) MEN1KMT2ACDK1CDK2ROCK1
SCHEMBL5578253 0.61 MEN1 (0.40) MEN1KMT2ACDK1CDK2MAPT
SCHEMBL5578275 0.61 JAK2 (0.46) MEN1KMT2ACDK1CDK2ROCK1
SCHEMBL5578220 0.60 CDK1 (0.41) MEN1KMT2ACDK1CDK2ROCK1
SCHEMBL16017300 0.60 LMNA (0.43) MEN1KMT2ASTIM1ORAI1IRAK4
SCHEMBL5579217 0.60 MEN1 (0.41) MEN1KMT2ACDK1CDK2ROCK1
SCHEMBL3585842 0.59 MAPT (0.44) MEN1KMT2AMAPTHTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1836188-A1 PYRAZOLE DERIVATIVES AS THAT MODULATE THE ACTIVITY OF CDK, GSK AND AURORA KINASES Astex Therapeutics Limited (GB) 2007-09-26 EP disclosed
WO-2006070198-A1 PYRAZOLE DERIVATIVES AS THAT MODULATE THE ACTIVITY OF CDK, GSK AND AURORA KINASES ASTEX THERAPEUTICS LIMITED (GB) 2006-07-06 WO disclosed